BRINCIDOFOVIR (has an active metabolite) | BRINCIDOFOVIR | ATC J05AB12
ANTIINFECTIVES ORTHOPOXVIRUS NUCLEOTIDE ANALOG DNA POLYMERASE INHIBITOR TREATMENT OF HUMAN SMALLPOX DISEASE ANTIVARIOLA METABOLIZED BY SPHINGOMYELINASE | ORAL | Cmax 854.5 NANOMOLAR Tmax 3 HOUR F 16.8 PERCENT VD 1230 LITER PPB 99.9 PERCENT Cl 44.1 LITER / HOUR HT 19.3 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | DNA POLYMERASE | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |